ProStrakan will market Cellegy's Rectogesic in Europe
Specialty pharma company ProStrakan Group (formed through the 2004 merger of Strakan Pharmaceuticals and ProSkelia) has taken on European marketing of a second product, Rectogesic, for partner Cellegy Pharmaceuticals.
- Specialty Pharmaceuticals
- Includes Contract
- Intra-Biotech Deal
- Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.